Protocols,annotated.

Retatrutide is described as targeting fat loss three ways: appetite suppression (minimal until higher doses), a shift in substrate utilisation via metabolic signalling so the body preferentially burns fat for energy, and an increase in basal metabolic rate — the stated explanation for the resting heart rate rise of 5–7 beats per minute reported on it.

Cagrilintide is described as increasing the effect on appetite suppression, so that retatrutide can reduce appetite and food noise at a lower dose than tirzepatide or other GLP-1s would require. It is also credited with reducing glucose spikes and slowing gastric emptying. Used together, the protocol states, they assist overall weight loss at significantly smaller doses — and smaller doses mean fewer side effects.

As specified

• Increase retatrutide by 0.5 mg every 4 weeks — but only if weight loss has plateaued for at least 2 weeks straight (4 weeks for women), and only if there are zero side effects.

KLOW is described as providing deep tissue healing, tendon and structural repair, muscle repair, a large reduction in systemic and local inflammation, and increased collagen and skin integrity — including help with excess skin elasticity during weight loss.

The protocol states KLOW must be cycled, but that two of its components — BPC-157 and TB-500 — never need cycling, and have been shown to affect chronic issues around the eight-to-nine month mark, so the longer you stay on them the better the effect. Hence the rotation: when cycling off KLOW, move to the Wolverine stack in between.

The combination and cycle is described as reducing muscle loss from retatrutide/cagrilintide when combined with a high-protein diet and heavy resistance training — entirely mitigating muscle loss and even producing muscle gain during fat loss.

As specified

• Take KLOW for 4 vials, then switch to the Wolverine blend at 1 mg for 2 vials, then back to KLOW again.
• Zinc may need to be added to balance copper levels — but because of zinc maximum daily limits, it is best to get labs first.

Tesamorelin is described as urging the body to naturally release growth hormone in a powerful pulse, and as cutting visceral fat stores by an average of 15% over 26 weeks — working with the reta/cagri stack to reduce it further. The growth hormone pulse is credited with significant additional benefit for muscle repair, retention and recovery.

Ipamorelin is described as pairing synergistically to increase GH production without cortisol spikes or prolactin increases, leading to enhanced slow-wave sleep and further boosting muscle growth, fat loss and metabolic baseline.

As specified

• Tesamorelin: take for 4 vials, then take a 4-week break before beginning again.
• Ipamorelin: take for 2 vials, then take a 4-week break before beginning again.
• Both dosed 2 hours fasted; go to sleep after.

Described as clearing brain fog, sharpening mental drive, relaxing the nervous system, and lessening or removing anxiety — by naturally raising BDNF, boosting natural dopamine, modulating GABA, lowering cortisol and protecting enkephalins, providing an overall "calm".

The protocol states plainly: always take Semax and Selank together.

As specified

• Take each for 1 vial (roughly 20 days), then cycle off for an equal amount of time.
• Never dose either after 2pm.

Start with SS-31 to address current structural stress and repair it — 5 mg daily for 10 days (one whole vial). This repairs the current system. Then step back to a maintenance level of 5 mg two to three times per week.

Then add MOTS-c to encourage the mitochondria to function at full capacity again: 1 mg the first week, 0.5 mg three times a week the second week, then 0.5 mg each morning for ten weeks. The protocol notes that at the beginning there are energy spikes followed by exhaustion, and that as repairs occur this switches to substantial energy with no exhaustion.

Then add Epitalon — 1 mg daily for 10 days, repeated only yearly — described as stimulating telomeres to lengthen (reversing ageing damage), reducing and reversing oxidative stress from premature ageing and cell damage, resetting immune system strength, repairing melatonin production for natural sleep, and repairing circadian rhythm.

As specified

• MOTS-c fasted: no food for at least 30 minutes after. Near-zero-calorie caffeine is fine with NO BCAAs. Electrolytes are also fine.
• MOTS-c: take for 4 vials then take a 4-week break before beginning again.
• SS-31: 1 vial daily, then 2–3× weekly for 8 weeks, then off for 4 weeks; cycle on/off.

Retatrutide drives thermogenesis, hepatic lipid oxidation and appetite suppression via triple agonism. Cagrilintide adds long-acting amylin and calcitonin receptor agonism, synergising centrally to curb hedonic eating via hindbrain satiety centres without compounding nausea. 5-Amino-1MQ inhibits NNMT in white adipose tissue, elevating intracellular NAD⁺ and SIRT1 activity and shifting adipocytes from a storage to a high-expenditure phenotype.

BPC-157 upregulates growth hormone receptors, accelerates angiogenesis via VEGF pathways and restores gut mucosal barrier integrity. TB-500 promotes actin sequestration, cellular migration and tissue remodelling. KLOW adds GHK-Cu for collagen synthesis and matrix metalloproteinase modulation, and KPV for mast-cell stabilisation and anti-inflammatory action.

MOTS-c translocates to the nucleus under metabolic stress, activating AMPK and improving insulin sensitivity. Humanin protects against oxidative stress, apoptosis and amyloid toxicity via STAT3 and IGF-1 signalling. NAD⁺ replenishes coenzyme pools needed for PARP repair enzymes and sirtuin pathways. Epitalon restores melatonin synthesis, is claimed to lengthen telomeres via telomerase activation, and normalises neuroendocrine-immune interactions.

Thymosin Alpha-1 modulates thymic function, maturing naive T-cells and augmenting dendritic cell maturation to balance Th1/Th2 responses. Glutathione, the master endogenous antioxidant, binds electrophilic xenobiotics via Phase II GST enzymes, neutralising reactive oxygen species and protecting hepatic parenchyma.

Semax and Selank enhance BDNF/NGF expression and modulate GABAergic tone, driving focus and stress resilience. Ipamorelin and CJC-1295 without DAC stimulate synergistic pulsatile GH secretion without spiking cortisol or prolactin. Kisspeptin-10 stimulates GPR54 receptors in the hypothalamus, initiating GnRH release to restore downstream LH and sex-hormone pulsatility.

A non-selective melanocortin receptor agonist (MC1R, MC3R, MC4R, MC5R) stimulating eumelanin synthesis for photoprotection and melanogenesis, with secondary central appetite-suppressant and pro-erectile effects. The non-selectivity is precisely why it produces effects the user did not ask for.